Diagnostic and Biotech

Italy Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape

  • VPG22635
  • 402 Pages
  • July 2014
  • Diagnostic and Biotech

Complete report $2,450.  DataPack (test volumes, sales forecasts, supplier shares) $1,450.  The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. 



This new study from Venture Planning Group contains 410 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testig for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years. 



Report Highlights



- Market shares of leading suppliers

- Business and technological trends in major markets

- Five-year test volume and sales forecasts

- Market shares of leading competitors

- Feature comparison of major analyzers

- Strategic profiles of leading market players and start-up firms developing innovative products

- Specific product and business opportunities for instrument and consumable suppliers.



Rationale



Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry.  The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches.  The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.  In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.  Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.



Japan Market Overview



- Laboratories performing DNA sequencing and molecular diagnostic testing by country and market segment.



- Five-year test volume and sales projections.



Market Segmentation Analysis



- Five-year test volume and sales projections:



- Infectious Diseases        - Forensic Testing

- Cancer                            - Paternity Testing/HLA Typing

- Genetic Diseases            - Others



- A comprehensive analysis of the sequencing market by laboratory segment.

  

- Detailed market segmentation analysis, including review of the market dynamics, trends,

  structure, size, growth and major suppliers.



Product/Technology Review



- Comparison of the major molecular diagnostic analyzers.



- Extensive review of molecular diagnostic technologies, test formats, detection methodologies,

  trends in testing automation and over target/signal amplification methods.



- Worldwide listings of companies, universities and research centers developing new molecular

   diagnostic technologies and products.



Competitive Assessments



- Extensive strategic assessments of major suppliers and emerging market entrants,

  including their sales, product portfolios, marketing tactics, collaborative arrangements and

  new technologies/products in R&D.

  

   - Abbott

   - Affymetrix

   - Agilent Technologies

   - Applied Gene Technologies

   - Arca/Nuvelo

   - Beckman Coulter/Danaher

   - Becton Dickinson

   - Biokit

   - BioMerieux

   - Bio-Rad

   - Biotest

   - Caliper

   - Cepheid

   - Decode

   - Diadexus

   - Eiken

   - Enzo

   - Exact Sciences

   - Fujirebio/Innogenetics

   - Grifols

   - Hologic/Gen-Probe

   - Illumina

   - Kreatech

   - Li-Cor Biosciences

   - Life Technologies/Thermo Fisher

   - Monogram Biosciences

   - Myriad Genetics

   - Nanogen/Elitech

   - Orchid CellMark

   - Ortho-Clinical Diagnostics

   - Proteome Sciences

   - Qiagen              

   - Roche

   - Scienion

   - Sequenom

   - Shimadzu

   - Siemens

   - Sierra Molecular

   - Takara Bio

   - Tecan Group



- Comprehensive listings of companies developing and marketing molecular

  diagnostic products, by test and application.



Opportunities and Strategic Recommendations



- Specific new product development opportunities with potentially significant market appeal

  during the next five years.



- Design criteria for new products.



- Alternative market penetration strategies.



- Potential market entry barriers and risks.



- Business planning issues and concerns.



Contains 410 pages


Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Forensic Technologies Market (Service, Products and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Forensic technology is used for identification, interpretation and assessment of substantial evidences gathered from site of crime. Forensic science has witnessed tremendous developments in its technologies which in turn have ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Renal Biomarkers Market (Marker Type, Assay Platform, Application and Geography) - Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2020

Renal biomarkers help diagnose or identify the patients at risk of developing kidney diseases, by measuring their blood or urine levels. They are commonly released in acute or chronic kidney ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global C-Reactive Protein Testing Market (Application, Types of Assays and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

C-Reactive Protein Tests are blood tests that measure the levels of C-Reactive Protein. C-reactive protein is a protein that is produced by the liver and its level increase when there ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Exocrine Pancreatic Insufficiency Market (Mode of Disease management, Type of diagnostic tests and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2021

Exocrine pancreatic insufficiency (EPI) is an inability of proper digestion of food owing to insufficient levels of digestive enzymes from pancreas. EPI is commonly found in humans affected with Shwachman-Diamond ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

European NGS Services Market - Opportunities and Forecasts, 2015 - 2020

Next Generation Sequencing (NGS) services, also known as high-throughput sequencing, is term used to describe sequencing technologies, such as Illumina sequencing, Roche 454 sequencing, and SOLiD sequencing. These technologies enable ...

July 2017  |   Price:$ 3390    | Pre Book Price:$ 3390

Read More >>

Global Malaria Diagnostics Market (Technique and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Malaria is caused by the Plasmodium parasites and is transmitted by the female anopheles mosquito. Diagnosis of malaria includes detection by microscopy and blood tests. According to the WHO, in ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>